Revive Therapeutics | RVV Provides Update on its Clinical Development Plan for Cannabidiol in the Treatment of Autoimmune Hepatitis

TORONTO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”), a company…

Revive Enters into Psychedelics Market with Letter of Intent to Acquire Psilocin Pharma Corp.

News for Revive Therapeutics Ltd | RVV TORONTO, Feb. 12, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics…

Revive Therapeutics | RVV to buy truffles from Red Light for psychedelic market

REVIVE THERAPEUTICS TO PURSUE THE PSYCHEDELIC MARKET WITH AGREEMENT AND INVESTMENT IN RED LIGHT HOLLAND FINANCING…

New coverage in cannabis pharma sector with over 1300% upside potential | Revive Therapeutics

Introducing New Featured Stock Pick : Revive Therapeutics Ltd. | RVV The Cannabis Stock is proud to…